These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32625632)

  • 1. Guidance on the use of the weight of evidence approach in scientific assessments.
    ; Hardy A; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Benfenati E; Chaudhry QM; Craig P; Frampton G; Greiner M; Hart A; Hogstrand C; Lambre C; Luttik R; Makowski D; Siani A; Wahlstroem H; Aguilera J; Dorne JL; Fernandez Dumont A; Hempen M; Valtueña Martínez S; Martino L; Smeraldi C; Terron A; Georgiadis N; Younes M
    EFSA J; 2017 Aug; 15(8):e04971. PubMed ID: 32625632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.
    ; More S; Bampidis V; Benford D; Bragard C; Hernandez-Jerez A; Bennekou SH; Koutsoumanis K; Lambré C; Machera K; Mennes W; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Fletcher T; Greiner M; Ntzani E; Pearce N; Vinceti M; Vrijheid M; Georgiadis M; Gervelmeyer A; Halldorsson TI
    EFSA J; 2024 Jul; 22(7):e8866. PubMed ID: 38974922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Draft for internal testing Scientific Committee guidance on appraising and integrating evidence from epidemiological studies for use in EFSA's scientific assessments.
    ; More S; Bambidis V; Benford D; Bragard C; Hernandez-Jerez A; Bennekou SH; Koutsoumanis K; Machera K; Naegeli H; Nielsen SS; Schlatter JR; Schrenk D; Silano V; Turck D; Younes M; Fletcher T; Greiner M; Ntzani E; Pearce N; Vinceti M; Ciccolallo L; Georgiadis M; Gervelmeyer A; Halldorsson TI
    EFSA J; 2020 Aug; 18(8):e06221. PubMed ID: 32831946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The principles and methods behind EFSA's Guidance on Uncertainty Analysis in Scientific Assessment.
    ; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Younes M; Craig P; Hart A; Von Goetz N; Koutsoumanis K; Mortensen A; Ossendorp B; Germini A; Martino L; Merten C; Mosbach-Schulz O; Smith A; Hardy A
    EFSA J; 2018 Jan; 16(1):e05122. PubMed ID: 32625670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidance on harmonised methodologies for human health, animal health and ecological risk assessment of combined exposure to multiple chemicals.
    ; More SJ; Bampidis V; Benford D; Bennekou SH; Bragard C; Halldorsson TI; Hernández-Jerez AF; Koutsoumanis K; Naegeli H; Schlatter JR; Silano V; Nielsen SS; Schrenk D; Turck D; Younes M; Benfenati E; Castle L; Cedergreen N; Hardy A; Laskowski R; Leblanc JC; Kortenkamp A; Ragas A; Posthuma L; Svendsen C; Solecki R; Testai E; Dujardin B; Kass GE; Manini P; Jeddi MZ; Dorne JC; Hogstrand C
    EFSA J; 2019 Mar; 17(3):e05634. PubMed ID: 32626259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on protocol development for EFSA generic scientific assessments.
    ; More S; Bampidis V; Benford D; Bragard C; Hernández-Jerez A; Bennekou SH; Koutsoumanis KP; Lambré C; Machera K; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Younes M; Kraft A; Naegeli H; Tsaioun K; Aiassa E; Arcella D; Barizzone F; Cushen M; Georgiadis M; Gervelmeyer A; Lanzoni A; Lenzi P; Lodi F; Martino L; Messens W; Ramos Bordajandi L; Rizzi V; Stancanelli G; Supej Š; Halldorsson TI
    EFSA J; 2023 Oct; 21(10):e08312. PubMed ID: 37908452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on Communication of Uncertainty in Scientific Assessments.
    ; Hart A; Maxim L; Siegrist M; Von Goetz N; da Cruz C; Merten C; Mosbach-Schulz O; Lahaniatis M; Smith A; Hardy A
    EFSA J; 2019 Jan; 17(1):e05520. PubMed ID: 32626067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific motivations and criteria to consider updating EFSA scientific assessments.
    ; Hardy A; Benford D; Halldorsson T; Jeger MJ; Knutsen KH; More S; Mortensen A; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Brock T; Chesson A; Karenlampi S; Lambre C; Sanz Y; Goumperis T; Kleiner J; Maurici D
    EFSA J; 2017 Mar; 15(3):e04737. PubMed ID: 32625443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EFSA's framework for evidence-based scientific assessments: A case study on uncertainty analysis.
    Aiassa E; Merten C; Martino L
    ALTEX; 2022; 39(3):451–462. PubMed ID: 34185094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on Uncertainty Analysis in Scientific Assessments.
    ; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Younes M; Craig P; Hart A; Von Goetz N; Koutsoumanis K; Mortensen A; Ossendorp B; Martino L; Merten C; Mosbach-Schulz O; Hardy A
    EFSA J; 2018 Jan; 16(1):e05123. PubMed ID: 32625671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.
    Devos Y; Aguilera J; Diveki Z; Gomes A; Liu Y; Paoletti C; du Jardin P; Herman L; Perry JN; Waigmann E
    Transgenic Res; 2014 Feb; 23(1):1-25. PubMed ID: 23963741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance for establishing and applying tolerable upper intake levels for vitamins and essential minerals: Draft for internal testing.
    ; Turck D; Bohn T; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Peláez C; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Aggett P; Crous Bou M; Cubadda F; de Sesmaisons Lecarré A; Martino L; Naska A
    EFSA J; 2022 Jan; 20(1):e200102. PubMed ID: 35106096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opinion on the impact of non-monotonic dose responses on EFSA's human health risk assessments.
    ; More S; Benford D; Hougaard Bennekou S; Bampidis V; Bragard C; Halldorsson T; Hernandez-Jerez A; Koutsoumanis K; Lambré C; Machera K; Mullins E; Nielsen SS; Schlatter J; Schrenk D; Turck D; Tarazona J; Younes M
    EFSA J; 2021 Oct; 19(10):e06877. PubMed ID: 34712366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidance on risk assessment of nanomaterials to be applied in the food and feed chain: human and animal health.
    ; More S; Bampidis V; Benford D; Bragard C; Halldorsson T; Hernández-Jerez A; Hougaard Bennekou S; Koutsoumanis K; Lambré C; Machera K; Naegeli H; Nielsen S; Schlatter J; Schrenk D; Silano Deceased V; Turck D; Younes M; Castenmiller J; Chaudhry Q; Cubadda F; Franz R; Gott D; Mast J; Mortensen A; Oomen AG; Weigel S; Barthelemy E; Rincon A; Tarazona J; Schoonjans R
    EFSA J; 2021 Aug; 19(8):e06768. PubMed ID: 34377190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter to the editor regarding the article 'EFSA's toxicological assessment of aspartame: was it even-handedly trying to identify possible unreliable positives and unreliable negatives?'.
    Kass GEN; Lodi F
    Arch Public Health; 2020; 78():14. PubMed ID: 32266067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When the weight of evidence does not weigh enough: EFSA's draft scientific opinion on BPA.
    Zagorski JW; Kaminski NE
    Toxicol Sci; 2023 May; 193(2):115-118. PubMed ID: 37052529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance on the assessment of the biological relevance of data in scientific assessments.
    ; Hardy A; Benford D; Halldorsson T; Jeger MJ; Knutsen HK; More S; Naegeli H; Noteborn H; Ockleford C; Ricci A; Rychen G; Schlatter JR; Silano V; Solecki R; Turck D; Younes M; Bresson JL; Griffin J; Hougaard Benekou S; van Loveren H; Luttik R; Messean A; Penninks A; Ru G; Stegeman JA; van der Werf W; Westendorf J; Woutersen RA; Barizzone F; Bottex B; Lanzoni A; Georgiadis N; Alexander J
    EFSA J; 2017 Aug; 15(8):e04970. PubMed ID: 32625631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidance Document on Scientific criteria for grouping chemicals into assessment groups for human risk assessment of combined exposure to multiple chemicals.
    ; More SJ; Bampidis V; Benford D; Bragard C; Hernandez-Jerez A; Bennekou SH; Halldorsson TI; Koutsoumanis KP; Lambré C; Machera K; Naegeli H; Nielsen SS; Schlatter JR; Schrenk D; Silano V; Turck D; Younes M; Benfenati E; Crépet A; Te Biesebeek JD; Testai E; Dujardin B; Dorne JLC; Hogstrand C
    EFSA J; 2021 Dec; 19(12):e07033. PubMed ID: 34976164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFSA's OpenFoodTox: An open source toxicological database on chemicals in food and feed and its future developments.
    Dorne JLCM; Richardson J; Livaniou A; Carnesecchi E; Ceriani L; Baldin R; Kovarich S; Pavan M; Saouter E; Biganzoli F; Pasinato L; Zare Jeddi M; Robinson TP; Kass GEN; Liem AKD; Toropov AA; Toropova AP; Yang C; Tarkhov A; Georgiadis N; Di Nicola MR; Mostrag A; Verhagen H; Roncaglioni A; Benfenati E; Bassan A
    Environ Int; 2021 Jan; 146():106293. PubMed ID: 33395940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guidance on scientific principles and data requirements for the safety and relative bioavailability assessment of new micronutrient sources.
    ; Turck D; Bohn T; Castenmiller J; de Henauw S; Hirsch-Ernst KI; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Pentieva K; Siani A; Thies F; Tsabouri S; Vinceti M; Kass G; Heng L; Sofroniou A; Ververis E; Valtueña Martínez S; Naska A
    EFSA J; 2024 Sep; 22(9):e8946. PubMed ID: 39351444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.